Hecht Foundation’s commitment will continue and expand the current NCCAM funded Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study.
Research Studies
Status: Active
Study area: Oncology
Principal investigator: Leanna J. Standish, ND, PhD, LAc, FABNO
Funded by: Hecht Foundation
Project period: 1/1/13 – 12/31/18
Status: Recruiting
Study area: Neurology
Principal investigator: Laurie K Mischley, ND
Project period: 03/08/2013-03/31/2018
The goal of this PD study is to collect as much data as possible over a five-year period with the hope of finding dietary and lifestyle factors associated with a slower disease progression.
To participate in this study please email neuroresearch[at]bastyr[dot]edu
Status: Recruiting
Study area: Neurology
Principal investigator: Laurie Mischley, ND
Project period: 09/01/2012 - 08/31/2017
Multiple sclerosis is often said to be an incurable, progressive, and degenerative disease. It is our hypothesis that some of you do not, or will not, have a progressive disease. The goal of this MS study is to collect as much data as possible over a five-year period with the hope of fiding dietary and lifestyle factors associated with a slower disease progression.
Status: Recruiting
Study area: Oncology
Principal investigator: Leanna Standish, Leanna J. Standish, ND, Ph.D, Lac, FABNO
Co-investigator(s): Cynthia Wenner, Ph.D, Celestia Higano, MD (Seattle Cancer Care Alliance/UW)
Funded by: National Center for Complementary and Alternative Medicine (NIH/NCCAM)
Project period: 2013 – 2014
The NIH/NCCAM funded a clinical trial for prostate cancer patients at Bastyr University/University of Washington’s Mushroom Cancer Research Center. The purpose of the study is to test the safety and tolerability of consuming the mushroom supplement, and to detect the modulation of their immune functions in laboratory assays
Status: Active
Study area: Neurology
Principal investigator: Laurie Mischley, ND, MPH
Funded by: NIH/NCCAM
Project period: 01/01/10 - 12/31/14
Parkinson's disease (PD) is considered a progressive and irreversible neurodegenerative disease. Current therapies improve disease symptoms, however none alter the underlying degenerative course. Research suggests the loss of brain glutathione, a powerful antioxidant, is one of the earliest changes to occur in the brain of PD patients and the magnitude of glutathione depletion parallels the severity of PD. This study will look at the use of intranasal glutathione in PD patients to determine safety, tolerability, and the impact on PD symptoms.
Status: Active
Study area: Oncology
Principal investigator: NIH/NCCAM (U19) Partnership with University of Washington
Co-investigator(s): Leanna Standish, Mary L. (Nora) Disis
Project period: September 29, 2010, to August 31, 2014
The Bastyr University/University of Washington PCCTR Oncomycology Research Center will investigate the immunologic and antitumor effects of Trametes versicolor (Tv) a traditional Chinese medicine medicinal mushroom, for use in the treatment of prostate cancer and breast cancer patients in the U.S
Status: Active
Study area: Oncology
Principal investigator: Hailing Lu (University of Washington)
Co-investigator(s): Cynthia Wenner, PhD
Project period: April 2010 – March 2014
Clinical management of locally advanced breast cancer remains challenging as patients have a high risk for relapse, especially those patients whose tumors over-express the HER-2/neu (HER2+) oncogenic protein and have limited expression of estrogen receptors (ER-).
Status: Active
Study area: Neurology
Principal investigator: Laurie Mischley, ND
Project period: January 2010 – December 2014
Parkinson's disease (PD) is considered a progressive and irreversible neurodegenerative disease. Current therapies improve disease symptoms, however none alter the underlying degenerative course.
Status: Active
Study area: Other
Principal investigator: James Taylor (UW PI); Erica Oberg (Bastyr PI)
Funded by: International Scientific Committee on Homeopathic Investigation
Project period: 12/01/2012 - 11/30/2013
This study compares the genomic response in those who receive homeopathic verum to those who receive a placebo.
Knowledge, Attitudes & Personal Health Practices of Naturopathic Physicians in Practice and Training
Status: Recruiting
Study area: CAM Research / Education
Principal investigator: Erica Oberg, ND, MPH
Funded by: Bastyr University
Project period: 2008-2013